This company listing is no longer active
Provention Bio Management
Management criteria checks 2/4
Key information
Ashleigh Palmer
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 29.8% |
| CEO tenure | 6.5yrs |
| CEO ownership | 2.7% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | US$2m | US$675k | -US$114m |
| Sep 30 2022 | n/a | n/a | -US$106m |
| Jun 30 2022 | n/a | n/a | -US$105m |
| Mar 31 2022 | n/a | n/a | -US$104m |
| Dec 31 2021 | US$2m | US$613k | -US$114m |
| Sep 30 2021 | n/a | n/a | -US$121m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$118m |
| Dec 31 2020 | US$2m | US$595k | -US$99m |
| Sep 30 2020 | n/a | n/a | -US$77m |
| Jun 30 2020 | n/a | n/a | -US$55m |
| Mar 31 2020 | n/a | n/a | -US$45m |
| Dec 31 2019 | US$4m | US$500k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$38m |
| Jun 30 2019 | n/a | n/a | -US$34m |
| Mar 31 2019 | n/a | n/a | -US$33m |
| Dec 31 2018 | US$584k | US$425k | -US$27m |
| Sep 30 2018 | n/a | n/a | -US$25m |
| Jun 30 2018 | n/a | n/a | -US$21m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$778k | US$290k | -US$9m |
Compensation vs Market: Ashleigh's total compensation ($USD2.27M) is above average for companies of similar size in the German market ($USD1.68M).
Compensation vs Earnings: Ashleigh's compensation has increased whilst the company is unprofitable.
CEO
Ashleigh Palmer (59 yo)
6.5yrs
Tenure
US$2,266,108
Compensation
Mr. Ashleigh W. Palmer, B.Sc., M.B.A., is Co-Founder, President, Chief Executive Officer and Director of Provention Bio, Inc. since October 4, 2016. Mr. Palmer served as Chief Executive Officer and Preside...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.5yrs | US$2.27m | 2.71% $ 58.2m | |
| Co-Founder & Chief Scientific Officer | 6.5yrs | US$1.16m | 1.13% $ 24.3m | |
| Chief Medical Officer | 3.3yrs | US$1.16m | 0.074% $ 1.6m | |
| Chief Financial Officer | 1.3yrs | US$2.24m | no data | |
| Chief Operations Officer | 1.3yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Legal Officer | 2.7yrs | no data | no data | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Vice President Marketing | no data | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Senior Vice President of Clinical Development | 3.7yrs | no data | no data | |
| Chief Commercial Officer | 3.3yrs | US$5.61m | 0% $ 0 |
3.3yrs
Average Tenure
46yo
Average Age
Experienced Management: 2VB's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.5yrs | US$2.27m | 2.71% $ 58.2m | |
| Independent Director | 4.6yrs | US$168.04k | 0.021% $ 453.2k | |
| Independent Director | 2.9yrs | US$159.08k | 0% $ 0 | |
| Independent Chairman | 5yrs | US$198.36k | 0.0079% $ 169.9k | |
| Independent Director | 2.7yrs | US$150.22k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data |
3.8yrs
Average Tenure
64yo
Average Age
Experienced Board: 2VB's board of directors are considered experienced (3.8 years average tenure).